共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 |
R017717-1g
当天发货 |
1g | 现货 |
水溶性四氮唑-8 2-(2-Methoxy-4-nitrophenyl)-... |
98% |
|
|
罗恩 | R017717-250mg | 250mg | 5~7个工作日 |
水溶性四氮唑-8 2-(2-Methoxy-4-nitrophenyl)-... |
98% |
|
|
罗恩 | R203066-1ml | 1ml | 现货 |
水溶性四氮唑-8 2-(2-Methoxy-4-nitrophenyl)-... |
10mM in H2O |
|
|
阿拉丁 | W113061-250mg | 250mg | 现货 |
水溶性四氮唑-8(WST-8) WST-8 |
≥98% |
|
|
阿拉丁 | W113061-1g | 1g | 现货 |
水溶性四氮唑-8(WST-8) WST-8 |
≥98% |
|
|
阿拉丁 | W113061-50mg | 50mg | 现货 |
水溶性四氮唑-8(WST-8) WST-8 |
≥98% |
|
|
阿拉丁 | W113061-5g | 5g | 现货 |
水溶性四氮唑-8(WST-8) WST-8 |
≥98% |
|
|
阿拉丁 | W422359-1ml | 1ml | 期货,请咨询 |
水溶性四氮唑-8 WST-8 |
10mM in Water |
|
|
凯为 | JZ003ASN-100mg | 100mg | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2H-Tetrazolium, 5-(2,4-disul... |
99% |
|
|
凯为 | JZ003ASN-250mg | 250mg | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2H-Tetrazolium, 5-(2,4-disul... |
99% |
|
|
凯为 | JZ003ASN-1g | 1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2H-Tetrazolium, 5-(2,4-disul... |
99% |
|
|
凯为 | JZ003ASN-5g | 5g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2H-Tetrazolium, 5-(2,4-disul... |
99% |
|
|
乐研 | 1084656-1g | 1g | 现货 |
WST-8 WST-8 |
97% |
|
|
乐研 | 1084656-5g | 5g | 现货 |
WST-8 WST-8 |
97% |
|
|
乐研 | 1084656-100mg | 100mg | 现货 |
WST-8 WST-8 |
97% |
|
|
乐研 | 1084656-250mg | 250mg | 现货 |
WST-8 WST-8 |
97% |
|
|
毕得 | BD166972-250mg | 250mg | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(3-(2-Methoxy-4-nitropheny... |
95% |
|
|
毕得 | BD166972-1g | 1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(3-(2-Methoxy-4-nitropheny... |
95% |
|
|
毕得 | BD166972-100mg | 100mg | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(3-(2-Methoxy-4-nitropheny... |
95% |
|
|
毕得 | BD166972-5g | 5g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(3-(2-Methoxy-4-nitropheny... |
95% |
|
|
韶远 | SY016317-0.5g | 0.5g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY016317-1g | 1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY016317-0.1g | 0.1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY016317-5g | 5g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY233450-0.1g | 0.1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
>99% |
|
|
韶远 | SY233450-0.5g | 0.5g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
>99% |
|
|
韶远 | SY016317-10g | 10g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY016317-0.25g | 0.25g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
≥95% |
|
|
韶远 | SY233450-1g | 1g | 现货 |
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-... 2-(2-Methoxy-4-nitrophenyl)-... |
>99% |
|
|
百灵威 | JK668556-1G | 1G | 1天 |
水溶性四氮唑-8 WST-8, 99% |
99% |
|
|
百灵威 | JK668556-250MG | 250MG | 1天 |
水溶性四氮唑-8 WST-8, 99% |
99% |
|
|
百灵威 | JK668556-5g | 5g | 1天 |
水溶性四氮唑-8 WST-8, 99% |
99% |
|
|
百灵威 | JK668556-50MG | 50MG | 1天 |
水溶性四氮唑-8 WST-8, 99% |
99% |
|
|
源叶 | S31505-50mg | 50mg | 现货 |
水溶性四氮唑-8 WST-8 |
98% |
|
|
源叶 | S31505-250mg | 250mg | 现货 |
水溶性四氮唑-8 WST-8 |
98% |
|
|
源叶 | S31505-1g | 1g | 现货 |
水溶性四氮唑-8 WST-8 |
98% |
|
|
源叶 | S31505-5g | 5g | 现货 |
水溶性四氮唑-8 WST-8 |
98% |
|
|
Target Mol | T4018-25mg | 25mg | 现货 |
化合物WST8 WST-8 |
99.93% |
|
|
Target Mol | T4018-50mg | 50mg | 现货 |
化合物WST8 WST-8 |
99.93% |
|
|
Target Mol | T4018-100mg | 100mg | 现货 |
化合物WST8 WST-8 |
99.93% |
|
|
Target Mol | T4018-200mg | 200mg | 现货 |
化合物WST8 WST-8 |
99.93% |
|
|
Am | A427585-25mg | 25mg | 现货 |
WST-8 WST-8 |
95% |
|
|
Am | A427585-1g | 1g | 现货 |
WST-8 WST-8 |
95% |
|
|
Am | A427585-100mg | 100mg | 现货 |
WST-8 WST-8 |
95% |
|
|
Am | A427585-50mg | 50mg | 现货 |
WST-8 WST-8 |
95% |
|
|
Am | A427585-250mg | 250mg | 现货 |
WST-8 WST-8 |
95% |
|
|
MCE | HY-D0831-200mg | 200mg | 现货 |
WST-8 WST-8 |
99.67% |
|
|
MCE | HY-D0831-100mg | 100mg | 现货 |
WST-8 WST-8 |
99.67% |
|
|
MCE | HY-D0831-50mg | 50mg | 现货 |
WST-8 WST-8 |
99.67% |
|
|
MCE | HY-D0831-10mM*1mL | 10mM*1mL | 现货 |
WST-8 WST-8 |
99.67% |
|
|
MCE | HY-D0831-25mg | 25mg | 现货 |
WST-8 WST-8 |
99.67% |
|
|